nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ABCB1—adrenal gland cancer	0.683	1	CbGaD
Naloxone—CREB1—adrenal medulla—adrenal gland cancer	0.0469	0.601	CbGeAlD
Naloxone—TLR4—adrenal gland—adrenal gland cancer	0.00742	0.0952	CbGeAlD
Naloxone—CYP3A4—urine—adrenal gland cancer	0.00375	0.0481	CbGeAlD
Naloxone—CREB1—gonad—adrenal gland cancer	0.00375	0.0481	CbGeAlD
Naloxone—CREB1—pituitary gland—adrenal gland cancer	0.00366	0.0469	CbGeAlD
Naloxone—CREB1—adrenal gland—adrenal gland cancer	0.00327	0.0419	CbGeAlD
Naloxone—ALB—adrenal gland—adrenal gland cancer	0.00151	0.0193	CbGeAlD
Naloxone—ESR1—gonad—adrenal gland cancer	0.00148	0.0189	CbGeAlD
Naloxone—ESR1—pituitary gland—adrenal gland cancer	0.00144	0.0185	CbGeAlD
Naloxone—ESR1—adrenal gland—adrenal gland cancer	0.00129	0.0165	CbGeAlD
Naloxone—CYP2C8—pituitary gland—adrenal gland cancer	0.00119	0.0152	CbGeAlD
Naloxone—Naltrexone—ABCB1—adrenal gland cancer	0.000988	0.425	CrCbGaD
Naloxone—Buprenorphine—ABCB1—adrenal gland cancer	0.000726	0.313	CrCbGaD
Naloxone—ABCB1—adrenal cortex—adrenal gland cancer	0.000704	0.00903	CbGeAlD
Naloxone—Morphine—ABCB1—adrenal gland cancer	0.000608	0.262	CrCbGaD
Naloxone—ABCB1—gonad—adrenal gland cancer	0.000583	0.00747	CbGeAlD
Naloxone—ABCB1—pituitary gland—adrenal gland cancer	0.000569	0.00729	CbGeAlD
Naloxone—ABCB1—adrenal gland—adrenal gland cancer	0.000508	0.00651	CbGeAlD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000147	0.00062	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000147	0.000619	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—EGFR—adrenal gland cancer	0.000146	0.000618	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000146	0.000618	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000146	0.000617	CbGpPWpGaD
Naloxone—CREB1—Disease—SPRY2—adrenal gland cancer	0.000145	0.000612	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000143	0.000603	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000141	0.000598	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000141	0.000595	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.00014	0.000593	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00014	0.000592	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000139	0.000586	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—EGFR—adrenal gland cancer	0.000138	0.000585	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000137	0.000578	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000136	0.000575	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000136	0.000575	CbGpPWpGaD
Naloxone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000134	0.000567	CbGpPWpGaD
Naloxone—CREB1—Disease—MEN1—adrenal gland cancer	0.000133	0.000561	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000133	0.00056	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000131	0.000555	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00013	0.00055	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000128	0.000541	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.000127	0.000538	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000127	0.000537	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—RRM1—adrenal gland cancer	0.000126	0.000534	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SDHD—adrenal gland cancer	0.000126	0.000534	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000124	0.000523	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000124	0.000522	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTNNB1—adrenal gland cancer	0.000122	0.000517	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000121	0.000512	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00012	0.000507	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00012	0.000506	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00012	0.000505	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000119	0.000502	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000118	0.000499	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000117	0.000493	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000116	0.000492	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000113	0.000479	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000113	0.000476	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000112	0.000472	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	0.000112	0.000472	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—BAD—adrenal gland cancer	0.000112	0.000471	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000111	0.00047	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000111	0.000469	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000111	0.000468	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000111	0.000467	CbGpPWpGaD
Naloxone—CREB1—Immune System—PRKACA—adrenal gland cancer	0.00011	0.000464	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.000109	0.000462	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000109	0.00046	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000108	0.000455	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—BAD—adrenal gland cancer	0.000107	0.000452	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000107	0.000451	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000106	0.000448	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000105	0.000444	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000104	0.000439	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000103	0.000436	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—EGFR—adrenal gland cancer	0.000102	0.000431	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000102	0.00043	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000102	0.000429	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000101	0.000429	CbGpPWpGaD
Naloxone—CREB1—Disease—PRKACA—adrenal gland cancer	0.000101	0.000428	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000101	0.000427	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TSHR—adrenal gland cancer	9.89e-05	0.000418	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	9.86e-05	0.000416	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SPARC—adrenal gland cancer	9.81e-05	0.000414	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	9.81e-05	0.000414	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MED12—adrenal gland cancer	9.8e-05	0.000414	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—GNAS—adrenal gland cancer	9.74e-05	0.000411	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	9.7e-05	0.00041	CbGpPWpGaD
Naloxone—TLR4—Immune System—EGFR—adrenal gland cancer	9.7e-05	0.00041	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	9.7e-05	0.00041	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SDHB—adrenal gland cancer	9.63e-05	0.000407	CbGpPWpGaD
Naloxone—ALB—Metabolism—SDHB—adrenal gland cancer	9.58e-05	0.000405	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	9.44e-05	0.000399	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—MED12—adrenal gland cancer	9.42e-05	0.000398	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	9.37e-05	0.000396	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MEN1—adrenal gland cancer	9.36e-05	0.000396	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9.36e-05	0.000395	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	9.35e-05	0.000395	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDC42—adrenal gland cancer	9.31e-05	0.000393	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MEN1—adrenal gland cancer	9.3e-05	0.000393	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	9.27e-05	0.000391	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—EGFR—adrenal gland cancer	9.23e-05	0.00039	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	9.22e-05	0.00039	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	8.91e-05	0.000376	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	8.87e-05	0.000375	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	8.87e-05	0.000375	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	8.64e-05	0.000365	CbGpPWpGaD
Naloxone—CREB1—Disease—CDC42—adrenal gland cancer	8.6e-05	0.000363	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	8.51e-05	0.000359	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.42e-05	0.000356	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SDHB—adrenal gland cancer	8.39e-05	0.000354	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—CTNNB1—adrenal gland cancer	8.31e-05	0.000351	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	8.29e-05	0.00035	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PRKACA—adrenal gland cancer	8.28e-05	0.00035	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	8.19e-05	0.000346	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	8.13e-05	0.000343	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	7.92e-05	0.000335	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.74e-05	0.000327	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.58e-05	0.00032	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.54e-05	0.000318	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	7.53e-05	0.000318	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	7.49e-05	0.000317	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CTNNB1—adrenal gland cancer	7.34e-05	0.00031	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	7.3e-05	0.000309	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNRH1—adrenal gland cancer	7.27e-05	0.000307	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	7.2e-05	0.000304	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	7.19e-05	0.000304	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.17e-05	0.000303	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PRKACA—adrenal gland cancer	7.1e-05	0.0003	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	7.07e-05	0.000299	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CDC42—adrenal gland cancer	7.02e-05	0.000297	CbGpPWpGaD
Naloxone—CREB1—Disease—TERT—adrenal gland cancer	6.9e-05	0.000291	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.88e-05	0.000291	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PRKACA—adrenal gland cancer	6.87e-05	0.00029	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	6.87e-05	0.00029	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IGF2—adrenal gland cancer	6.77e-05	0.000286	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.71e-05	0.000284	CbGpPWpGaD
Naloxone—ALB—Hemostasis—GNAS—adrenal gland cancer	6.71e-05	0.000283	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SPRY2—adrenal gland cancer	6.65e-05	0.000281	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—EGFR—adrenal gland cancer	6.58e-05	0.000278	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—POMC—adrenal gland cancer	6.56e-05	0.000277	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	6.53e-05	0.000276	CbGpPWpGaD
Naloxone—CREB1—Immune System—BAD—adrenal gland cancer	6.5e-05	0.000274	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TSHR—adrenal gland cancer	6.48e-05	0.000274	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	6.31e-05	0.000267	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.28e-05	0.000265	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—RRM1—adrenal gland cancer	6.21e-05	0.000262	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SDHD—adrenal gland cancer	6.21e-05	0.000262	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	6.2e-05	0.000262	CbGpPWpGaD
Naloxone—ALB—Metabolism—SDHD—adrenal gland cancer	6.17e-05	0.000261	CbGpPWpGaD
Naloxone—ALB—Metabolism—RRM1—adrenal gland cancer	6.17e-05	0.000261	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.16e-05	0.00026	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MEN1—adrenal gland cancer	6.09e-05	0.000257	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CDC42—adrenal gland cancer	6.02e-05	0.000254	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	6e-05	0.000253	CbGpPWpGaD
Naloxone—CREB1—Disease—BAD—adrenal gland cancer	6e-05	0.000253	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—EGFR—adrenal gland cancer	5.81e-05	0.000246	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.81e-05	0.000245	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IGF2—adrenal gland cancer	5.8e-05	0.000245	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	5.78e-05	0.000244	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	5.78e-05	0.000244	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GNAS—adrenal gland cancer	5.75e-05	0.000243	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	5.73e-05	0.000242	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	5.73e-05	0.000242	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.7e-05	0.000241	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IGF1R—adrenal gland cancer	5.61e-05	0.000237	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	5.59e-05	0.000236	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—EGFR—adrenal gland cancer	5.58e-05	0.000236	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GNAS—adrenal gland cancer	5.57e-05	0.000235	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ABCB1—adrenal gland cancer	5.46e-05	0.000231	CbGpPWpGaD
Naloxone—CREB1—Disease—BRAF—adrenal gland cancer	5.46e-05	0.000231	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.41e-05	0.000228	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.41e-05	0.000228	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	5.33e-05	0.000225	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	5.26e-05	0.000222	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	5.24e-05	0.000221	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	5.17e-05	0.000218	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.09e-05	0.000215	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	5.07e-05	0.000214	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	5.03e-05	0.000212	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	4.9e-05	0.000207	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.88e-05	0.000206	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	4.84e-05	0.000205	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TERT—adrenal gland cancer	4.83e-05	0.000204	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	4.81e-05	0.000203	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PRKACA—adrenal gland cancer	4.65e-05	0.000196	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MED12—adrenal gland cancer	4.63e-05	0.000195	CbGpPWpGaD
Naloxone—ALB—Metabolism—MED12—adrenal gland cancer	4.6e-05	0.000194	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	4.45e-05	0.000188	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—adrenal gland cancer	4.41e-05	0.000186	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	4.29e-05	0.000181	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTNNB1—adrenal gland cancer	4.27e-05	0.000181	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	4.25e-05	0.000179	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	4.22e-05	0.000178	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—BAD—adrenal gland cancer	4.2e-05	0.000177	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	4.19e-05	0.000177	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	4.14e-05	0.000175	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.14e-05	0.000175	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.11e-05	0.000174	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.1e-05	0.000173	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MED12—adrenal gland cancer	4.03e-05	0.00017	CbGpPWpGaD
Naloxone—CREB1—Disease—CTNNB1—adrenal gland cancer	3.95e-05	0.000167	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDC42—adrenal gland cancer	3.94e-05	0.000167	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—POMC—adrenal gland cancer	3.87e-05	0.000164	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	3.86e-05	0.000163	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—BRAF—adrenal gland cancer	3.82e-05	0.000162	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	3.81e-05	0.000161	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IGF2—adrenal gland cancer	3.8e-05	0.000161	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNAS—adrenal gland cancer	3.77e-05	0.000159	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—POMC—adrenal gland cancer	3.75e-05	0.000158	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EGFR—adrenal gland cancer	3.71e-05	0.000157	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	3.69e-05	0.000156	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IGF1R—adrenal gland cancer	3.67e-05	0.000155	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	3.67e-05	0.000155	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	3.57e-05	0.000151	CbGpPWpGaD
Naloxone—CREB1—Immune System—EGFR—adrenal gland cancer	3.39e-05	0.000143	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	3.38e-05	0.000143	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	3.38e-05	0.000143	CbGpPWpGaD
Naloxone—ALB—Metabolism—PRKACA—adrenal gland cancer	3.36e-05	0.000142	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	3.34e-05	0.000141	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.33e-05	0.000141	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.33e-05	0.000141	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.3e-05	0.000139	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.28e-05	0.000139	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	3.24e-05	0.000137	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TERT—adrenal gland cancer	3.16e-05	0.000134	CbGpPWpGaD
Naloxone—CREB1—Disease—EGFR—adrenal gland cancer	3.13e-05	0.000132	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	3.1e-05	0.000131	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—adrenal gland cancer	2.99e-05	0.000126	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.94e-05	0.000124	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	2.86e-05	0.000121	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.82e-05	0.000119	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.76e-05	0.000117	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.75e-05	0.000116	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—BAD—adrenal gland cancer	2.75e-05	0.000116	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	2.74e-05	0.000116	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNAS—adrenal gland cancer	2.74e-05	0.000116	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNAS—adrenal gland cancer	2.72e-05	0.000115	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	2.68e-05	0.000113	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCB1—adrenal gland cancer	2.67e-05	0.000113	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—POMC—adrenal gland cancer	2.54e-05	0.000107	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—BRAF—adrenal gland cancer	2.5e-05	0.000106	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.48e-05	0.000105	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.42e-05	0.000102	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.38e-05	0.000101	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EGFR—adrenal gland cancer	2.19e-05	9.25e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	2.18e-05	9.22e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—adrenal gland cancer	2.14e-05	9.06e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.04e-05	8.62e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	1.91e-05	8.08e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—POMC—adrenal gland cancer	1.84e-05	7.78e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—adrenal gland cancer	1.84e-05	7.77e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	1.83e-05	7.74e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—POMC—adrenal gland cancer	1.83e-05	7.74e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.81e-05	7.65e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.81e-05	7.65e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.62e-05	6.83e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	1.61e-05	6.79e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—POMC—adrenal gland cancer	1.6e-05	6.78e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	1.47e-05	6.21e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.47e-05	6.2e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—adrenal gland cancer	1.46e-05	6.17e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.44e-05	6.09e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EGFR—adrenal gland cancer	1.43e-05	6.06e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	1.36e-05	5.74e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.28e-05	5.41e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—adrenal gland cancer	1.2e-05	5.09e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—POMC—adrenal gland cancer	9.89e-06	4.18e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	7.89e-06	3.33e-05	CbGpPWpGaD
